We hypothesize that P2-HNF4α expression is an early event in the development of HCC in NAFLD that is followed at a later step by STAT3 phosphorylation and c-Myc expression. The gene discussed is HNF4A; the disease is metabolic dysfunction-associated steatotic liver disease.